Plastic and Reconstructive Surgery • January 2019 on the physical, psychological, and social aspects of their life. 1, 2 Health-related quality of life can change over time, varying with changes in the condition itself, support network available, or other extrinsic factors. 3 The face plays an important role in social interactions 4, 5 ; therefore, all three aspects of health-related quality of life can be affected by facial scarring and deformity. Unsurprisingly, facial scarring and disfigurement can lead to a number of psychosocial difficulties 3, 6 and significantly reduce health-related quality of life. 7 To improve health-related quality of life in these patients, it is important that soft-tissue reconstructive options address both form and function. Furthermore the reconstructive options offered should be appropriately appraised by the patients who will ultimately benefit from them. Traditionally, the outcomes of facial reconstruction have been assessed using nonobjective or clinician-reported measures. However, this is beginning to change. 8 Patient-reported outcome measures are standardized and validated questionnaires that are completed by patients to capture one or more aspects of their health and well-being. 9 ,10 They are broadly described as being generic (assessing general aspects of health) or disease-specific (covering aspects that are specific and pertinent to someone with that condition), with benefits and disadvantages to the use of either type. 11 The use of patientreported outcome measures for the measurement of health-related quality of life has increased in recent years, with the U.K. Department of Health routinely collecting patient-reported outcome measures data on four surgical conditions 10 and the U.S. Food and Drug Administration mandating their use in drug labeling. 2 Furthermore, the use of patient-reported outcome measures in clinical trials has become commonplace in many specialties, with recent consensus-based recommendations for the inclusion of patient-reported outcome measures in the design of clinical trial protocols designed to further increase their use. 12 Despite their increasing use, there is a paucity of psychometrically robust patient-reported outcome measures as demonstrated by a number of systematic reviews. [13] [14] [15] [16] This is particularly important if treatment decisions, study outcomes, or adverse event reporting are to be based on their results. Psychometric validation of a patientreported outcome measure is complex, testing the questionnaire and its individual items for validity, reliability, responsiveness to change, and clinical meaning. This validation process is described in greater detail elsewhere, 11, 17 with some of the important terminology explained in Table 1 .
Choosing the correct patient-reported outcome measure to use based on its applicability to the condition of interest and its validity is therefore crucially important, especially if selecting instruments for inclusion in a core outcome set, where an agreed minimum set of outcomes is expected when reporting research in a specific disease area. 18, 19 The importance of soft-tissue facial reconstruction in helping to restore form and function and limiting the impact of facial scarring and deformity on health-related quality of life mandates the need for reconstructive options to be assessed 
PATIENTS AND METHODS

Search Strategy and Selection Criteria
A systematic review protocol was developed a priori in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols guidance. 20, 21 The search strategy was constructed in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, 22 the Cochrane handbook, 23 and guidance from Terwee et al. 24 A sensitive, rather than specific approach was taken to the search strategy, with three separate constructs used (i.e., target condition, target body area, and measurement instrument). Key words or Medical Subject Headings terms were used where available. All searches were performed by two independent researchers (T.D.D. and A.P.) on the same day in February of 2017 using the MEDLINE (Ovid), Embase (Ovid), PsychINFO (Ovid), and Cochrane databases. Results were uploaded to Distiller SR (Evidence Partners, Ottawa, Ontario, Canada) and duplicates removed. Gray literature (nontraditional or non-peer-reviewed publications such as annual reports, government documents, and unpublished literature) searching using Google, Google Scholar, and known patient-reported outcome measure-based websites was also conducted. All studies were screened according to the inclusion and exclusion criteria ( Table 2 ) by four reviewers (T.D.D., J.A.G.G., A.T., and B.P.), ensuring that all articles were screened by at least two reviewers. Articles that matched the inclusion criteria were downloaded in full-text format and rescreened (T.D.D. and J.A.G.G.). References were also searched to identify any previously missed studies. Discrepancies were discussed between the two reviewers and a third reviewer (H.A.H.) was consulted if required. The search strategy was rerun before submission in February of 2018 to identify any new articles.
Data Extraction and Analysis
Data required for the following analyses were extracted from each article and collated in Word and Excel for Mac (V14.5.7; Microsoft Corp., Redmond, Wash.). Interrater reliability statistics were calculated using IBM SPSS Version 22 (IBM Corp., Armonk, N.Y.). Results are presented as tables and a narrative synthesis.
Assessment of the Methodologic Quality and Psychometric Properties of Included Studies
The Consensus-based Standards for the Selection of Health Measurement Instruments (COS-MIN) steering committee recently published guidelines on conducting systematic reviews of patient-reported outcome measures. 25 These include an updated version of the COSMIN checklist for assessing the methodologic quality and risk of bias in studies reporting on patientreported outcome measure development and validation. [26] [27] [28] The updated COSMIN risk-ofbias checklist assesses 10 specific areas: patientreported outcome measure development, content validity, structural validity, internal consistency, cross-cultural validity and measurement invariance, reliability, measurement error, criterion validity, hypothesis testing for construct validity, and responsiveness. 28, 29 Each section is scored on a five-category scale (i.e., very good, adequate, Plastic and Reconstructive Surgery • January 2019 doubtful, inadequate, and not-applicable), with the lowest score in each category considered the final overall rating for the methodologic quality in that category for the article assessed (i.e., if internal consistency is rated as "very good" on one question, but "doubtful" on another, the overall score for internal consistency in the article being assessed is "doubtful"). All articles included in this review were assessed against these criteria, with summary scores presented for each patientreported outcome measure.
The original COSMIN checklist demonstrated reasonable interrater reliability, 30 with the new version being produced in the attempt to improve this further. However, because of there still being a degree of subjectivity, it is considered good practice to compare the results of two independent reviewers. A randomly selected 30 percent sample of studies was assessed by two reviewers (T.D.D. and S.H.) and the category scores compared using percentage agreement and intraclass coefficient. 31 It was decided a priori that if agreement were low, all studies would be doubly reviewed.
Each study was also assessed for its psychometric quality using criteria developed by Terwee et al. 32 and recently updated by Prinsen et al. 25 [See 
Evidence Synthesis and the Grading of Recommendation Assessment, Development and Evaluation Analysis
The results of the two assessments described above were pooled and used to produce a global score for each measurement property of each patient-reported outcome measure as outlined by Prinsen et al. 25 Results can be positive (+), negative (−), inconsistent (±), or indeterminate (?), with a "75 percent in agreement" rule used (i.e., for a positive outcome on structural validity, 75 percent or more of the studies reporting structural validity must be positive). 29 The quality of the evidence contributing to this outcome was graded using a modified version of the Grading of Recommendation Assessment, Development and Evaluation approach for systematic reviews of clinical trials. 25, 33 Those measurement categories with an indeterminate (?) score cannot be graded, as no evidence has been presented in the studies assessed. Finally, the combined results of each measurement category and Grading of Recommendation Assessment, Development and Evaluation analysis were used to formulate recommendation on the appropriateness of each patient-reported outcome measure for use in a soft-tissue facial reconstruction population.
Assessment of Reconstructive Relevance
Studies were selected based on their relevance to soft-tissue facial reconstruction. Despite this, a secondary assessment of the face validity, specifically relating to soft-tissue reconstruction, was performed. No precedent exists; therefore, the authors made a subjective assessment of all items in each included patient-reported outcome measure, allowing recommendations for future item and patient-reported outcome measure generation to be made where required.
RESULTS
After removal of duplicates, 16,165 individual titles and abstracts were screened. Seventeen additional articles were added following reference screening, leading to 34 studies being included ( Fig. 1) . These 34 studies presented evidence for the design and/or validation of nine patientreported outcome measures for soft-tissue facial reconstruction: FACE-Q, Patient Outcomes of Surgery-Head/Neck, Patient Scar Assessment Questionnaire, Nasal Appearance and Function Evaluation Questionnaire, Lip Reanimation Outcome Questionnaire, Rhinoplasty/Facelift/Blepharoplasty/Skin Rejuvenation Outcomes Evaluation, Patient and Observer Scar Assessment Scale, Skin Cancer Index, and Derriford Appearance Scale 59/24. A summary of these nine patient-reported outcome measures is presented in Table 3 . Table 4 presents a summary of the cumulative COSMIN outcomes for each measurement property for those included patient-reported outcome measures. Patient-reported outcome measure development and content validity was deemed "doubtful" or "inadequate" for all but FACE-Q, Skin Cancer Index, and Derriford Appearance Scale 59/24 and even then only Skin Cancer Index scored "adequate" or "very good" for both. Internal consistency was examined in all patientreported outcome measures and was deemed "very good" for all. Structural validity and reliability were also assessed in all patient-reported outcome measures; however, the other measurement properties were reported sporadically.
Methodologic Quality and Psychometric Properties of Included Studies
Average agreement between the two independent COSMIN reviewers was 93.6 percent, with an intraclass correlation coefficient of 0.844 (95 percent CI, 0.808 to 0.874), demonstrating good agreement. The psychometric properties of each study were also assessed as detailed earlier under Patients and Methods. Plastic and Reconstructive Surgery • January 2019 Plastic and Reconstructive Surgery • January 2019 summary of the cumulative score for each measurement category for each patient-reported outcome measure, based on the "best score wins" approach to summarizing each individual article for each patient-reported outcome measure into a summary score. A number of articles reported very little detail on psychometric validation and therefore a significant number have been given an indeterminate (?) result, as there is not enough to give either a positive (+) or a negative (−) result. The FACE-Q and the Derriford Appearance Scale 59/24 are the two patientreported outcome measures with the highest number of positive ratings.
Evidence Synthesis and Grading of Recommendation Assessment, Development and Evaluation Analysis
To provide an overall assessment of each individual patient-reported outcome measure and adjust for poor-quality evidence, the results of Tables 4 and 5 were pooled and a modified Grading of Recommendation Assessment, Development and Evaluation analysis performed according to the method described previously. Four patient-reported outcome measures-the FACE-Q, Skin Cancer Index, Patient and Observer Scar Assessment Scale, and Derriford Appearance Scale 59/24-had high-quality levels of evidence for those measurement properties that could be assessed. All of the remaining patient-reported outcome measures were downgraded in terms of evidence quality, mainly because of small participant numbers or only single studies of adequate quality on an individual patient-reported outcome measure. The results of this are presented in Table 6 . Finally, to provide recommendations for the use of patient-reported outcome measures in soft-tissue facial reconstruction in the future, each patient-reported outcome measure was categorized according to its potential ( Table 7) . The FACE-Q, Skin Cancer Index, Patient Outcomes of Surgery-Head/Neck, and Derriford Appearance Scale 59/24 all demonstrated enough high-quality evidence of their methodologic and psychometric properties to be considered an A grade patientreported outcome measure.
Assessment of Reconstructive Relevance
The items included in each patient-reported outcome measure were assessed for their specific relevance to soft-tissue reconstruction as judged by the authors. Summary findings are presented in Table 8 .
DISCUSSION
This systematic review has been designed to identify patient-reported outcome measures that have either been designed for, or validated in, a soft-tissue facial reconstruction population. Internationally recognized best practice was used to appraise the quality of evidence and risk of bias in studies reporting on the design and validation of those included patient-reported outcome measures. 25, 27, 28 Other methods for assessing the psychometric properties of a patient-reported outcome measure exist. 2, 68 However, the COS-MIN checklist is now routinely used in systematic reviews of patient-reported outcome measures across many specialities such as orthopedics, 69 pediatrics, 70 dermatology, 71 and neurology 72 and should be incorporated into all patient-reported outcome measures-based systematic reviews in plastic and reconstructive surgery.
Of the nine patient-reported outcome measures identified as having been designed for or validated in an appropriate population, there are a range of conditions or facial areas on which they focus. All are condition-specific, patient-reported outcome measures, as it was felt that generic patient-reported outcome measures, although useful, would not have items that sufficiently covered aspects relevant to soft-tissue facial reconstruction and were therefore excluded. However, of those condition-specific patient-reported outcome measures included, some are narrowly focused (e.g., Nasal Appearance and Function Evaluation Questionnaire on nasal reconstruction), whereas some are more broadly applicable (e.g., FACE-Q) and others are on the cusp of being nonspecific but still relevant (e.g., Derriford Appearance Scale 59/24). Patient-reported outcome measures specifically designed for rhinoplasty were excluded for two reasons: first, because it was determined that a rhinoplasty involves more extensive tissue manipulation than just the soft tissues; and second, because there has been a recent systematic review that addresses this area. 73 The methodologic quality of the included studies as assessed using the COSMIN checklist varied widely, suggesting a significant risk of bias for many of the studies. When results were collated across studies for each patient-reported outcome measure, it was revealed that although some aspects of design and validation were done well (e.g., internal consistency), many were done poorly (e.g., content reliability and responsiveness) and some were only sporadically reported (e.g., measurement error and criterion validity). Plastic and Reconstructive Surgery • January 2019
The measurement properties of "patientreported outcome measure development" and "content validity" scored poorly across all patientreported outcome measures. This was likely the result of poor-quality qualitative work in the generation of items (such as insufficiently sized qualitative interview groups and inappropriate coding methods for theme generation), leading to poor ratings on the COSMIN checklist, and a general lack of good-quality reporting across studies.
As with any risk-of-bias assessment tool, one is reliant on the information being reported in the article to give a positive or negative result. However, it appears that the majority of older studies reported poorly on many aspects of patientreported outcome measure design and validation that are now considered to be important. Therefore, by definition, these studies will score poorly in many of these categories as scored using the COSMIN checklist. This makes it difficult to differentiate between those patient-reported outcome measures that have good content validity but lost points because of errors of omission in the reporting versus those that were poorly developed and lacked content validity. Evidence for psychometric validity was variable across all of the included patient-reported outcome measures, with many scoring "indeterminate" for the quality of a psychometric property because of a lack of reporting as described above.
Research performed with poor-quality patientreported outcome measures constitutes a waste of resources. 74 Poorly validated studies with little clinical meaning and high responder burden are not suitable for routine clinical practice and limit the benefit of patient-reported outcome measures for the surgeon in terms of the critical appraisal of outcomes. For these reasons, the combination of the COSMIN checklist 28 and the updated Terwee et al. checklist 25 to form a summary of the evidence base for each patient-reported outcome measure, as performed here, is crucial. In this systematic review, four patient-reported outcome measures were identified as having sufficient methodologic rigor and psychometric validity combined with high-quality evidence to be placed in grade A. These patient-reported outcome measures (i.e., FACE-Q, Skin Cancer Index, Patient Outcomes of Surgery-Head/Neck, and Derriford Appearance Scale 59/24) all therefore have the potential to be recommended as the most suitable patient-reported outcome measures for inclusion in a core outcome set for facial reconstruction. They do, however, all have deficiencies in their design and validation, which should be addressed through further large-scale psychometric evaluation. Furthermore, as can be seen from the assessment of their item focus on reconstruction, none is able to cover the full spectrum of likely concerns of a patient undergoing soft-tissue facial reconstruction. The FACE-Q and the scar-related patient-reported outcome measures (i.e., Patient Scar Assessment Questionnaire and Patient and Observer Scar Assessment Scale) have the greatest number of relevant questions (despite being designed for a cosmetic facial population and scarring, respectively), but all are still lacking in a number of key areas. Further item generation and validation is therefore required, either as a new patient-reported outcome measure or as additional items to one of the identified patientreported outcome measures. Soft-tissue facial reconstruction also encompasses a wide range of patients, from those with minor defects to those requiring large functional and aesthetic reconstructions. It is likely that a "one-size-fitsall" patient-reported outcome measure will not be able to address this spectrum of concerns and therefore multiple patient-reported outcome instruments or a split-design patient-reported outcome measure is required.
The use of the COSMIN checklist and guidance by Prinsen et al. 25 is a strength of this study. Despite the COSMIN checklist being considered the gold standard for appraising the patientreported outcome measure literature, it has its limitations. The checklist is extensive and requires knowledge of the health-outcomes literature, potentially making it inaccessible to the nonspecialist reader. Some sections are also subjective in parts, requiring the user to "read between the lines" of the assessed studies on occasion. To overcome this, two reviewers reviewed a 30 percent sample of articles to confirm that the percentage agreement and intraclass correlation coefficient between them was sufficient. We appreciate that other review teams could score sections differently, altering the final outcome.
A broad search strategy was used to identify all pertinent studies; however, only studies that demonstrated aspects of patient-reported outcome measure design or validation were included. Because patient-reported outcome measure validity was considered to be of utmost importance, this could mean that patient-reported outcome measures that include useful items but that have not been validated were missed. Furthermore, the decision to exclude both generic and pediatric patient-reported outcome measures was based on the aim of identifying those patient-reported outcome measures that would have items most relevant to the adult soft-tissue facial reconstruction patient. We appreciate that this decision may have led to potentially useful items being missed.
CONCLUSIONS
This is the first systematic review to identify patient-reported outcome measures for soft-tissue facial reconstruction. This review has identified a number of different patient-reported outcome measures, which have all to some degree been designed for, or validated in, patients undergoing soft-tissue facial reconstruction. Unfortunately, there is great variability in the quality of the validation process and, despite suggesting four patientreported outcome measures that would potentially be suitable for inclusion in a core outcome set for facial reconstruction, all of these instruments require further validation studies. In addition, for inclusion in a core outcome set, decisions with regard to delivery medium and preoperative and postoperative assessment timing would need to be made. Therefore, a patient-reported outcome measure including an amalgamation of items from all those identified patient-reported outcome measures, plus newly designed items, would best address the concerns of patients undergoing reconstructive procedures for soft-tissue facial deformities. The findings of this review suggest that there is a need for a new patient-reported outcome measure that includes items that measure functional, psychorelational, and cosmetic components of quality of life in these patients. All those involved in facial reconstruction are urged to take on the challenge of developing and validating such Plastic and Reconstructive Surgery • January 2019 a patient-reported outcome measure. In time, this will allow a core outcome set that can be agreed on, with treatments evaluated and improved according to the wishes of our patients. 
